Esophageal metal stent for malignant obstruction after prior radiotherapy
Open Access
- 22 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-8
- https://doi.org/10.1038/s41598-021-81763-x
Abstract
The association between severe adverse events (SAEs) and prior radiotherapy or stent type remains controversial. Patients with esophageal or esophagogastric junctional cancer who underwent stent placement (2005–2019) were enrolled in this retrospective study conducted at a tertiary cancer institute in Japan. The exclusion criteria were follow-up period of < 1 month and insufficient data on stent type or cancer characteristics. We used Mann–Whitney’s U test for quantitative data and Fisher’s exact test for categorical data. Multivariate analysis was performed using a logistic regression model. 107 stents were placed. Low radial-force stents (L group) were used in 51 procedures and high radial-force stents (H group) in 56 procedures. SAEs developed after nine procedures, the median interval from stent placement being 6 days (range, 1–141 days). SAEs occurred more frequently in the H (14%: 8/56) than in the L group (2%: 1/51) (P = 0.03). In patients who had undergone prior radiotherapy, SAEs were more frequent in the H (36%: 4/11) than in the L group (0%: 0/13) (P = 0.03). Re-obstruction and migration occurred after 16 and three procedures, respectively; these rates did not differ significantly between groups (P = 0.59, P = 1, respectively). Low radial-force stents may reduce the risk of SAEs after esophageal stenting.This publication has 34 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Comparison of 2 expandable stents for malignant esophageal disease: a randomized controlled trialGastrointestinal Endoscopy, 2012
- The impact of prior radiotherapy on fatal complications after self-expandable metallic stents (SEMS) for malignant dysphagia due to esophageal carcinomaDiseases of the Esophagus, 2012
- Quality of life in patients with esophageal stenting for the palliation of malignant dysphagiaWorld Journal of Gastroenterology, 2011
- Esophageal stents: past, present, and futureTechniques in Gastrointestinal Endoscopy, 2010
- The Use of Self-Expanding Stents in Esophageal and Gastroesophageal Junction Cancer Palliation: A Meta-Analysis and Meta-Regression Analysis of OutcomesDigestive Diseases and Sciences, 2010
- Measurement of radial and axial forces of biliary self-expandable metallic stentsGastrointestinal Endoscopy, 2009
- Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancerAlimentary Pharmacology & Therapeutics, 2006
- Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancyGastrointestinal Endoscopy, 1996
- Endoscopic Laser Therapy for Malignancies Affecting the Esophagus and Gastroesophageal JunctionArchives of Internal Medicine, 1985